MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Short-term Investments (2023 - 2026)

MetaVia's (MTVA) quarterly Short-term Investments came in at $32000.0 in Q4 2025, up 100.0% YoY from $16000.0 in Q4 2024, and up 433.33% on a QoQ basis from $6000.0 in Q3 2025.

MetaVia (MTVA) Short-term Investments (2023 - 2026) Analysis & Trends

MetaVia (MTVA) has 3 years of Short-term Investments data on file, last reported at $32000.0 in Q4 2025.

  • Quarterly Short-term Investments rose 100.0% year-over-year to $32000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32000.0 (up 100.0% YoY) and the FY2025 annual result came in at $32000.0, up 100.0% from the prior year.
  • Short-term Investments advanced to $32000.0 in Q4 2025, from $6000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $111000.0 in Q2 2024 to a low of $2000.0 in Q1 2025.
  • A 3-year average of $27500.0 and a median of $14000.0 in 2024 frame the typical range for Short-term Investments.
  • The widest YoY moves for Short-term Investments: up 100.0% in 2025, down 98.2% in 2025.
  • Tracing MTVA's Short-term Investments over 3 years: stood at $39000.0 in 2023, then slumped by 58.97% to $16000.0 in 2024, then surged by 100.0% to $32000.0 in 2025.
  • The last three Short-term Investments figures came in at $32000.0 (Q4 2025), $6000.0 (Q3 2025), and $2000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 MetaVia 8.72 Mn -3.92 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Dec 31, 2025 32,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 16,000.00
Sep 30, 2024 12,000.00
Jun 30, 2024 111,000.00
Dec 31, 2023 39,000.00